Universitätsklinikum Tübingen

Immune-Checkpoint-Blockade for Merkel Cell Carcinoma: Clinical and molecular Biomarker-Analysis (2020) Spassova I, Ugurel S, Zimmer L, Schadendorf D, Terheyden P, Andtback HB, Villabona L, et al. Conference contribution Effectiveness of Dabrafenib plus Trametinib during the Treatment of Melanoma Patients with BRAFV600 mutated Brain Metastases (2020) Berking C, Schadendorf D, Weichenthal M, Eigentler T, Schober K, Mohr P, Kiecker F, et al. Conference contribution Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic Sclerosis (2020) Belz D, Moinzadeh P, Riemekasten G, Henes J, Müller-Ladner U, Blank N, Koetter I, et al. Journal article Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (2020) Dörr HG, Schulze N, Bettendorf M, Binder G, Bonfig W, Denzer C, Dunstheimer D, et al. Journal article Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning (2020) Wustrau K, Greil J, Sykora KW, Albert MH, Burkhardt B, Lang P, Meisel R, et al. Journal article Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study (2020) Schmidt-Hegemann NS, Kroeze SGC, Henkenberens C, Vogel MME, Kirste S, Becker J, Burger IA, et al. Journal article RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial (2020) Martin D, Balermpas P, Gollrad J, Weiss C, Valentini C, Stuschke M, Schaefer H, et al. Journal article DETECT III und IV - Individualisierte CTC-basierte Therapie des HER2-negativen metastasierten Mammakarzinoms (2020) Friedl TWP, Schneeweiss A, Mueller , Riethdorf S, Pantel K, Taran FA, Polasik A, et al. Conference contribution DETECT V/CHEVENDO - duale HER2-zielgerichteten Therapie mit Trastuzumab und Pertuzumab plus Ribociclib in Kombination mit Chemotherapie oder endokriner Therapie bei Patientinnen mit HER2-positivem und hormonrezeptor-positivem metastasierten Mammakarzinom (2020) Friedl TWP, Polasik A, Tzschaschel M, Schochter F, De Gregorio A, Fasching P, Taran FA, et al. Conference contribution Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor–mediated Dysbiosis (2020) Pickert G, Wirtz S, Matzner J, Ashfaq-Khan M, Heck R, Rosigkeit S, Thies D, et al. Journal article